Aldeyra Therapeutics Inc (NASDAQ:ALDX)

7.41
Delayed Data
As of Sep 18
 +0.30 / +4.22%
Today’s Change
1.48
Today|||52-Week Range
8.05
+27.54%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Aldeyra Therapeutics Inc have a median target of 26.00, with a high estimate of 33.00 and a low estimate of 15.00. The median estimate represents a +250.88% increase from the last price of 7.41.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Aldeyra Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$0.00
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.40%
 
 
 
 
 
 
Growthannually 46.93%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.